{"nct_id":"NCT04611802","title":"A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2","status":"COMPLETED","status_verified_date":"2023-11","start_date":"2020-12-27","start_date_type":"ACTUAL","primary_completion_date":"2023-04-10","primary_completion_date_type":"ACTUAL","completion_date":"2023-12-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVAX"]}